研究者データベース - 喜里山　暁子

キリヤマ　アキコ KIRIYAMA Akiko
喜里山　暁子

所属同志社女子大学薬学部医療薬学科

職種准教授

著書・論文歴
著書	ナノバイオテクノロジーの応用展開～ナノマテリアルの創製とデバイス開発～,1-249頁 (共著) 2005
論文	ラットを用いた抗糖尿病薬・グリメピリドと抗脂血症薬・ベザフィブラートの併用効果－薬物動態学/薬力学解析を用いた基礎的検討－同志社女子大学総合文化研究所紀要第41巻,45-56頁 (共著) 2024/07
論文	抗悪性腫瘍薬・ダカルバジンのラットを用いた薬物動態学的モデル解析の基礎的検討同志社女子大学　総合文化研究所紀要第39巻,118-129頁 (共著) 2022/07
論文	α2-Antiplasmin as a potential regulator of the spatial memory process and age-related cognitive decline. Mol. Brain 13 (1),140 (共著) 2020/02
論文	Transnasal Delivery of the Peptide Agonist Specific to Neuromedin-U Receptor 2 to the Brain for the Treatment of Obesity. Mol. Pharmaceutics 17 (1),32-39頁 (共著) 2020/01
論文	Supramolecular Complexation in Biological Media: NMR Study on Inclusion of an Anionic Tetraarylporphyrin into a Per-O-Methylated β-Cyclodextrin Cavity in Serum, Blood, and Urine. Chem Asian J. 14 (19),3320-3328頁 (共著) 2019/08
論文	Novel strategy for the systemic delivery of furosemide based on a new drug transport mechanism Biological and Pharmaceutical Bulletin 41 (12),1769-1777頁 (共著) 2018/12
論文	Quantitative Estimation of the Effect of Nasal Mucociliary Function on In Vivo Absorption of Norfloxacin after Intranasal Administration to Rats Molecular Pharmaceutics 15 (10),4462-4469頁 (共著) 2018/10
論文	The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: Application to the prediction of nasal drug absorption European Journal of Pharmaceutical Sciences 117,21-26頁 (共著) 2018/05
論文	Delivery of oxytocin to the brain for the treatment of autism spectrum disorder by nasal application Molecular Pharmaceutics 15 (3),1105-1111頁 (共著) 2018/03
論文	Novel strategy for improving the bioavailability of curcumin based on a new membrane transport mechanism that directly involves solid particles. European Journal of Pharmaceutics and Biopharmaceutics 122 (1),1-5頁 (共著) 2018/01
論文	Usefulness of Two-Compartment Model-Assisted and Static Overall Inhibitory-Activity Method for Prediction of Drug-Drug Interaction Biological and Pharmaceutical Bulletin 40 (12),2024-2037頁 (共著) 2017/12
論文	Pharmacokinetic-Pharmacodynamic Analyses of Anti-diabetes, Glimepiride: Comparison of the Streptozotocin-Induced Diabetic, GK, and Wistar Rats Journal of Drug Metabolism and Toxicology 8 (2),1000229 (共著) 2017/08
論文	Simulations of cytochrome P450 3A4-mediated drug-drug interactions by simple two-compartment model-assisted static method Journal of Pharmaceutical Sciences 106 (5),1426-1438頁 (共著) 2017/05
論文	Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects Regulatory Toxicology and Pharmacology 76 (1),21-29頁 (共著) 2016/01
論文	Preparation and pharmaceutical evaluation of acetaminophen nano-fiber tablets: Application of a solvent-based electrospinning method for tableting Biomedicine and Pharmacotherapy 78 (1),14-22頁 (共著) 2016/01
論文	Intrinsic cell permeability of the GAGA zinc finger protein into HeLa cells. Biochem. Biophys. Re.s Commun. 464 (4),1034-1039頁 (共著) 2015/09
論文	Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery Therapeutic Delivery 4 (10),1261-1278頁 (共著) 2013/10
論文	Effects of physiological and biochemical factors based on aging, pathological conditions and drug combinations on propranolol pharmacokinetics using physiologically-based pharmacokinetic model in humans Biomedicine & Aging Pathology 3 (3),107-114頁 (共著) 2013/03
論文	Analysis of factors determining incomplete intestinal drug absorption as observed in cyclosporine formulations by use of tube model incorporated Nernst Equation Drug Metabolism Reviews Suppl. 1 42巻,43-44頁 (共著) 2010/08
論文	Binding of Multivalent Anionic Porphyrins to V3 Loop Fragments of an　HIV-1 Envelope and Their Antiviral Activity Chem. Asian J. 5,825-834頁 (共著) 2010/04
論文	Pharmacokinetic Profiles of Coenzyme Q10: Absorption of Three Different Oral Formulations in Rats Journal of Health Science Vol.55 (No.4),540-548頁 (共著) 2009/08
論文	Prediction of intestinal and hepatic first-pass effects in human using data of caco-2 cell permeability and oral clearance Drug Metabolism Reviews Suppl.1 Vol.41,28 (共著) 2009/05
論文	How greatly is the magnitude of drug-drug interaction influenced by administration time of inhibitor?: simulation of interaction after co-administration of melatonin with fluvoxamine by Dynamo-PK analysis method Drug Metabolism Reviews Suppl.1 Vol.40,80 (共著) 2008/05
論文	Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans International Journal of Pharmaceutics Vol.349 (No.1-2),53-60頁 (共著) 2008/02
論文	Effect of Physiological and Biochemical Parameters on Propranolol Pharmacokinetics Using a Physiologically-Based Pharmacokinetic Model in Humans Drug Metabolism Reviews. Supple.1 Vol.39,154 (共著) 2007/10
論文	How greatly is the magnitude of drug-drug interaction influenced by factors other than Imax/Ki of inhibitor?: simulation of interaction of rapidly-eliminating drugs with fluvoxamine by Dynamo-PK analysis method Drug Metabolism Reviews. Supple.1 Vol.39,124 (共著) 2007/10
論文	A Multi-sinusoidal Compartment Model as an Alternative to the Dispersion Model for Hepatic Extraction Kinetic Analysis 同志社女子大学学術研究年報 57巻,105-113頁 (共著) 2006/12
論文	生理学的モデルを用いたヒト血漿中薬物濃度の新しい予測法ファルマシア 42巻 (10号),1030 (単著) 2006/10
論文	Twoコンパートメント・ファーマコキネティック・モデル（TCBPK）を用いたダイナモPK―プロプラノロールの動態に及ぼす食事の効果のシミュレーション― 同志社女子大学総合文化研究所紀要 23巻,109-117頁 (共著) 2006/03
論文	Multi-compartment model as a possible alternative to dispersion model for hepatic extraction kinetic analysis Drug Metabolism Reviews Suppl.2 Vol.37,207-208頁 (共著) 2005
論文	Transport of macromolecules by M-cells: Study with in vitro M-cell model Drug Metabolism Reviews Suppl.2 Vol.37,274 (共著) 2005
論文	Metabolic characterization of a tripeptide HIV-1 protease inhibitor, KNI-272, in rat liver microsomes Antimicrob. Agents Chemother. Vol.43,549-556頁 (共著) 1999/05
論文	Physiologically based pharmacokinetics of KNI-272, a tripeptide HIV-1 protease inhibitor Biopharm. Drug Dispos. Vol.20,199-205頁 (共著) 1999/04
論文	Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor Biopharm. Drug Dispos. Vol.17,739-751頁 (共著) 1996/09
論文	The bioavailability of oral dosage forms of a new HIV-1 protease inhibitor, KNI-272, in beagle dogs Biopharm. Drug Dispos Vol.17,125-134頁 (共著) 1996
論文	Absorption of new HIV-1 protease inhibitor, KNI-272, after intraduodenal and intragastric administrations to rats: Effect of solvent Biopharm. Drug Dispos Vol.16,269-277頁 (共著) 1995
論文	Synthesis of -(methylthio) arylacetamides and their conversion into some biologically active arylethylamides. Chemical Pharmaceutical Bullletin 37,3396-3398頁 (共著) 1989/12